Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Income Statement [Abstract]    
Revenues $ 0 $ 0
Costs and Expenses    
Operating expenses 635,402 855,452
Research and development expenses 74,935 272,777
Loss before other income (expense) (710,337) (1,128,229)
Other income (expense)    
Other income 0 1,500
Interest and financing expense (493,712) (47,608)
Loss on disposition of equipment (3,343) 0
Net loss $ (1,207,392) $ (1,174,337)
Net loss per common share, basic and diluted $ (.01) $ (.01)
Weighted average common shares outstanding, basic and diluted 185,222,083 181,253,911